Research Article
Clinical Effects of Activated Charcoal Unavailability on Treatment Outcomes for Oral Drug Poisoned Patients
Table 3
Charcoal availability and clinical outcome.
| ā | Charcoal-available period | Charcoal-unavailable period | p-value |
| Aspiration pneumonia, n (%) | 41 (9.9%) | 21 (9.5%) | 0.864 | Endotracheal intubation, n (%) | 35 (8.5%) | 16 (7.2%) | 0.586 | Vasopressor, n (%) | 22 (5.3%) | 11 (5.0%) | 0.850 | Mortality, n (%) | 8 (1.9%) | 2 (0.9%) | 0.507 | Hospital admission, n (%) | 179 (43.3%) | 66 (29.9%) | <0.001 | ICU admission, n (%) | 24 (5.8%) | 30 (13.6%) | <0.001 |
|
|
ICU: intensive care unit.
|